Applied Therapeutics, Inc. - Common Stock (NQ:APLT)

0.1030 UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Applied Therapeutics, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Applied Therapeutics to Present at the SVB Securities Global Biopharma Conference

February 09, 2023

From Applied Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 31, 2023

Via Benzinga

Why Applied Therapeutics Shares Are Seeing Blue Skies ↗

January 04, 2023

Applied Therapeutics Inc (NASDAQ: APLT) shares are trading higher by 15.99% to $0.87 Wednesday morning after the company announced a partnership with Advanz Pharma for the commercialization of AT-007...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 04, 2023

Via Benzinga

Recap: Applied Therapeutics Q2 Earnings ↗

August 12, 2022

Applied Therapeutics (NASDAQ:APLT) reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 04, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!

Via InvestorPlace

Applied Therapeutics Announces Partnership with Advanz Pharma for Commercialization of AT-007 (Govorestat) in Europe

January 04, 2023

From Applied Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 30, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 29, 2022

Via Benzinga

Applied Therapeutics Reports Third Quarter 2022 Financial Results

November 09, 2022

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics Announces Multiple Data Presentations at the American Heart Association Scientific Sessions November 5-7, 2022

October 31, 2022

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics Announces Full Enrollment in the Registrational Phase 3 ARISE-HF Trial of AT-001 in Diabetic Cardiomyopathy

October 25, 2022

From Applied Therapeutics

Via GlobeNewswire

Helbiz And 3 Other Stocks Under $1 Insiders Are Aggressively Buying ↗

October 17, 2022

The Dow Jones dropped by more than 400 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday ↗

October 17, 2022

Gainers Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45. FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52.

Via Benzinga

Why Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday's Mid-Day Session ↗

October 14, 2022

Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) surged 77.7% to $9.35.

Via Benzinga

Dow Dips Over 300 Points; Provention Bio Shares Spike Higher ↗

October 06, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 300 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 06, 2022

Gainers

Via Benzinga

Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday ↗

October 07, 2022

Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.

Via Benzinga

Nasdaq Edges Higher; AngioDynamics Shares Plummet ↗

October 06, 2022

U.S. stocks pared losses midway through trading, with the Nasdaq Composite turning higher on Thursday.

Via Benzinga

Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

October 06, 2022

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...

Via Benzinga

Applied Therapeutics' Lead Candidate Pediatric Study Failed To Reach Statistical Significance ↗

October 06, 2022

Applied Therapeutics Inc's (NASDAQ: APLT) ACTION-Galactosemia Kids Phase 3 trial has demonstrated a trend in clinical benefit favoring AT-007 vs. placebo.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 06, 2022

Gainers Statera BioPharma (NASDAQ:STAB) stock increased by 64.8% to $0.23 during Thursday's pre-market session. The company's market cap stands at $11.5 million.

Via Benzinga

Applied Therapeutics Announces Positive Data Trend in AT-007 ACTION-Galactosemia Kids Pediatric Trial; Trial Will Continue to 18 Months in Blinded Format

October 06, 2022

From Applied Therapeutics

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 18, 2022

It's time to take a look at the biggest pre-market stock movers for Thursday and the news that's got those shares moving!

Via InvestorPlace

TransDigm Group To $740? Also Check Out Some Other Major PT Changes ↗

August 16, 2022

Wells Fargo raised the price target on TransDigm Group Incorporated (NYSE: TDG) from $620 to $740. Wells Fargo analyst Matthew Akers maintained an Overweight rating on the stock. TransDigm Group shares...

Via Benzinga

Applied Therapeutics to Sponsor and Present at the 2022 Galactosemia Foundation Conference

July 28, 2022

From Applied Therapeutics

Via GlobeNewswire

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session ↗

June 30, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical...

Via Benzinga

Aspen Aerogels And 28 Stocks Moving Premarket ↗

June 30, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 29, 2022

Gainers

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.